Australia markets close in 2 hours 33 minutes
  • ALL ORDS

    7,067.40
    +24.70 (+0.35%)
     
  • ASX 200

    6,813.10
    +23.50 (+0.35%)
     
  • AUD/USD

    0.7755
    -0.0023 (-0.29%)
     
  • OIL

    59.80
    -0.84 (-1.39%)
     
  • GOLD

    1,712.50
    -10.50 (-0.61%)
     
  • BTC-AUD

    63,523.47
    +3,526.49 (+5.88%)
     
  • CMC Crypto 200

    986.43
    +58.20 (+6.27%)
     
  • AUD/EUR

    0.6442
    -0.0008 (-0.13%)
     
  • AUD/NZD

    1.0689
    -0.0002 (-0.02%)
     
  • NZX 50

    12,404.19
    +102.38 (+0.83%)
     
  • NASDAQ

    13,282.95
    +373.51 (+2.89%)
     
  • FTSE

    6,588.53
    +105.10 (+1.62%)
     
  • Dow Jones

    31,535.51
    +603.14 (+1.95%)
     
  • DAX

    14,012.82
    +226.53 (+1.64%)
     
  • Hang Seng

    29,703.83
    +251.26 (+0.85%)
     
  • NIKKEI 225

    29,588.89
    -74.61 (-0.25%)
     

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates UROV, WTRE, CBMG, NAV; Shareholders Are Encouraged to Contact the Firm

Halper Sadeh LLP
·2-min read

NEW YORK, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

Urovant Sciences Ltd. (NASDAQ: UROV) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Sumitovant Biopharma Ltd. for $16.25 per share. If you are an Urovant shareholder, click here to learn more about your rights and options.

Watford Holdings Ltd. (NASDAQ: WTRE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Arch Capital Group Ltd. for $35.00 per share. If you are a Watford shareholder, click here to learn more about your rights and options.

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a consortium that includes members of Cellular Biomedicine management and several entities. If you are a Cellular Biomedicine shareholder, click here to learn more about your rights and options.

Navistar International Corporation (NYSE: NAV) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Traton SE for $44.50 per share in cash. If you are a Navistar shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com